Clinical trial
Stroke Prevention in Sickle Cell Anemia (STOP 1)
NCT00000592 · Augusta University, Other · Completed
Key facts
| NCT number | NCT00000592 |
|---|---|
| Title | Stroke Prevention in Sickle Cell Anemia (STOP 1) |
| Lead sponsor | Augusta University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell, Cerebral Embolism and Thrombosis, Cerebrovascular Disorders, Hematologic Diseases, Hemoglobinopathies |
| Intervention type | Procedure |
| Interventions | blood transfusion |
| Start date | Jul 1, 1994 |
| Completion | Aug 1, 2000 |
| First posted | Oct 28, 1999 |
| Last update posted | Dec 23, 2015 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: